Treatment of STEMI | Ethnic Group |  |  χ2‡ | df# |  p§ | ||
---|---|---|---|---|---|---|---|
Malays | Chinese | Indians | Others* | ||||
No. (%) | No. (%) | No. (%) | No. (%) | ||||
Primary PCI | 188 (5.6) | 111 (9.0) | 93 (7.9) | 30 (7.4) | 40.7 | 6 | 0.000 |
Fibrinolysis | 2607 (78.1) | 858 (69.5) | 878 (74.3) | 307 (76.2) | |||
No reperfusion+ | 544 (16.3) | 265 (21.5) | 211 (17.9) | 66 (16.4) | |||
Total | 3339 (100.0) | 1234 (100.0) | 1182 (100.0) | 403 (100.0) | |||
Fibrinolysis subgroup | Â | Â | Â | Â | Â | Â | Â |
Type of fibrinolytic drug used | Â | Â | Â | Â | Â | Â | Â |
Streptokinase | 1924(97.1) | 671(98.0) | 661(96.2) | 238(97.9) | 4.3 | 3 | 0.226 |
Other fibrinolytic drugs | 58(2.9) | 14(2.0) | 26(3.8) | 5(2.1) | Â | Â | |
Door-to-needle time within 30 min | 559(8.4) | 181(5.9) | 217(6.9) | 54(7.5) | 20.3 | 3 | 0.000 |
Door-to-needle time (min)†| 50(27–100) | 55(30–101) | 49(24–102) | 59(30–116) | 10.7 | 3 | 0.013¥ (0.01, 0.02)¥ |
Door-to-balloon time (min)†| 112(78–168) | 109(73–156) | 96(71–165) | 81(48–124) | 10.4 | 3 | 0.018¥ (0.01,0.02)¥ |